• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
For avid glucose tumors, the SUV peak is the most reliable parameter for [(18)F]FDG-PET/CT quantification, regardless of acquisition time.对于葡萄糖代谢活跃的肿瘤,SUV 峰值是(18)F-FDG-PET/CT 定量最可靠的参数,与采集时间无关。
EJNMMI Res. 2016 Dec;6(1):21. doi: 10.1186/s13550-016-0177-8. Epub 2016 Mar 5.
2
Reproducibility of [18F]FDG PET/CT liver SUV as reference or normalisation factor.[18F]FDG PET/CT 肝脏 SUV 作为参考或标准化因素的可重复性。
Eur J Nucl Med Mol Imaging. 2023 Jan;50(2):486-493. doi: 10.1007/s00259-022-05977-5. Epub 2022 Sep 27.
3
Comparison of prone versus supine 18F-FDG-PET of locally advanced breast cancer: Phantom and preliminary clinical studies.局部晚期乳腺癌俯卧位与仰卧位18F-FDG-PET的比较:模型研究与初步临床研究
Med Phys. 2015 Jul;42(7):3801-13. doi: 10.1118/1.4921363.
4
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
5
Influence of Statistical Fluctuation on Reproducibility and Accuracy of SUVmax and SUVpeak: A Phantom Study.统计波动对SUVmax和SUVpeak的可重复性及准确性的影响:一项模体研究
J Nucl Med Technol. 2015 Sep;43(3):222-6. doi: 10.2967/jnmt.115.161745. Epub 2015 Aug 13.
6
Feasibility of equivalent performance of 3D TOF [F]-FDG PET/CT with reduced acquisition time using clinical and semiquantitative parameters.使用临床和半定量参数,在缩短采集时间的情况下,3D TOF [F]-FDG PET/CT等效性能的可行性。
EJNMMI Res. 2021 May 1;11(1):44. doi: 10.1186/s13550-021-00784-9.
7
Optimization of PET reconstruction algorithm, SUV thresholding algorithm and PET acquisition time in clinical 11C-acetate PET/CT.临床 11C-乙酸盐 PET/CT 中 PET 重建算法、SUV 阈值算法和 PET 采集时间的优化。
PLoS One. 2018 Dec 13;13(12):e0209169. doi: 10.1371/journal.pone.0209169. eCollection 2018.
8
Repeatability of Quantitative Whole-Body 18F-FDG PET/CT Uptake Measures as Function of Uptake Interval and Lesion Selection in Non-Small Cell Lung Cancer Patients.非小细胞肺癌患者全身18F-FDG PET/CT定量摄取测量的可重复性与摄取间隔及病变选择的关系
J Nucl Med. 2016 Sep;57(9):1343-9. doi: 10.2967/jnumed.115.170225. Epub 2016 Apr 21.
9
Sensitivity of F-fluorodihydrotestosterone PET-CT to count statistics and reconstruction protocol in metastatic castration-resistant prostate cancer.F-氟二氢睾酮PET-CT对转移性去势抵抗性前列腺癌计数统计和重建方案的敏感性
EJNMMI Res. 2019 Jul 30;9(1):70. doi: 10.1186/s13550-019-0531-8.
10
Metabolic Tumor Burden Assessed by Dual Time Point [F]FDG PET/CT in Locally Advanced Breast Cancer: Relation with Tumor Biology.双时间点[F]FDG PET/CT评估局部晚期乳腺癌的代谢肿瘤负荷:与肿瘤生物学的关系
Mol Imaging Biol. 2017 Aug;19(4):636-644. doi: 10.1007/s11307-016-1034-x.

引用本文的文献

1
Performance of PSMA-PET/CT as verified by bone biopsy for diagnosing osseous metastases of prostate cancer.经骨活检验证的PSMA-PET/CT在诊断前列腺癌骨转移中的性能。
Skeletal Radiol. 2025 Jul;54(7):1479-1489. doi: 10.1007/s00256-024-04855-5. Epub 2024 Dec 20.
2
Whole-body PET image denoising for reduced acquisition time.用于减少采集时间的全身PET图像去噪
Front Med (Lausanne). 2024 Sep 30;11:1415058. doi: 10.3389/fmed.2024.1415058. eCollection 2024.
3
FDG uptake of pulmonary lesions in synchronous primary lung cancers and lung metastases.同步性原发性肺癌和肺转移瘤中肺部病变的氟代脱氧葡萄糖摄取情况。
Res Diagn Interv Imaging. 2024 Mar 8;9:100041. doi: 10.1016/j.redii.2024.100041. eCollection 2024 Mar.
4
Evaluating the immunologically "cold" tumor microenvironment after treatment with immune checkpoint inhibitors utilizing PET imaging of CD4 + and CD8 + T cells in breast cancer mouse models.利用 PET 成像评估乳腺癌小鼠模型中免疫检查点抑制剂治疗后 CD4+和 CD8+T 细胞的免疫“冷”肿瘤微环境。
Breast Cancer Res. 2024 Jun 25;26(1):104. doi: 10.1186/s13058-024-01844-3.
5
New full-counts phase-matched data-driven gated (DDG) PET/CT.全新全计数相匹配数据驱动门控(DDG)PET/CT。
Med Phys. 2024 Jul;51(7):4646-4654. doi: 10.1002/mp.17097. Epub 2024 Apr 22.
6
Validation of the 2018 FIGO staging system for stage IIIC cervical cancer by determining the metabolic and radiomic heterogeneity of primary tumors based on F-FDG PET/CT.通过基于F-FDG PET/CT确定原发性肿瘤的代谢和放射组学异质性来验证2018年国际妇产科联盟(FIGO)IIIC期宫颈癌分期系统。
Abdom Radiol (NY). 2024 Jun;49(6):2027-2039. doi: 10.1007/s00261-024-04226-7. Epub 2024 Mar 25.
7
Evaluation of Malignancy Risk of Ampullary Tumors Detected by Endoscopy Using 2-[F]FDG PET/CT.经内镜检测壶腹肿瘤使用 2-[F]FDG PET/CT 的恶性肿瘤风险评估。
Korean J Radiol. 2024 Mar;25(3):243-256. doi: 10.3348/kjr.2023.0295.
8
FDG imaging with long-axial field-of-view PET/CT in patients with high blood glucose-a matched pair analysis.高血糖患者长轴向视野 PET/CT 的 FDG 成像——一项配对分析。
Eur J Nucl Med Mol Imaging. 2024 Jun;51(7):2036-2046. doi: 10.1007/s00259-024-06646-5. Epub 2024 Feb 22.
9
The Utility of F-FDG-PET-CT Metabolic Parameters in Evaluating the Primary Tumor Aggressiveness and Lymph Node Metastasis of Nasopharyngeal Carcinoma.F-FDG-PET-CT代谢参数在评估鼻咽癌原发肿瘤侵袭性和淋巴结转移中的应用
Clin Med Insights Oncol. 2024 Feb 5;18:11795549231225419. doi: 10.1177/11795549231225419. eCollection 2024.
10
Exploring Neoadjuvant Chemotherapy, Predictive Models, Radiomic, and Pathological Markers in Breast Cancer: A Comprehensive Review.探索乳腺癌的新辅助化疗、预测模型、放射组学和病理标志物:一项综述
Cancers (Basel). 2023 Nov 4;15(21):5288. doi: 10.3390/cancers15215288.

本文引用的文献

1
FDG PET/CT for assessing the resectability of NSCLC patients with N2 disease after neoadjuvant therapy.18F-氟代脱氧葡萄糖正电子发射断层显像/X线计算机体层成像用于评估新辅助治疗后N2期非小细胞肺癌患者的可切除性。
Ann Nucl Med. 2016 Feb;30(2):114-21. doi: 10.1007/s12149-015-1038-7. Epub 2015 Nov 27.
2
Impact of point spread function modelling and time of flight on FDG uptake measurements in lung lesions using alternative filtering strategies.使用替代滤波策略时,点扩散函数建模和飞行时间对肺部病变中FDG摄取测量的影响。
EJNMMI Phys. 2014 Dec;1(1):99. doi: 10.1186/s40658-014-0099-3. Epub 2014 Nov 30.
3
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描:欧洲核医学与分子影像学会肿瘤显像程序指南:第2.0版。
Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):328-54. doi: 10.1007/s00259-014-2961-x. Epub 2014 Dec 2.
4
[¹⁸F]FDG positron emission tomography within two weeks of starting erlotinib therapy can predict response in non-small cell lung cancer patients.[¹⁸F]FDG 正电子发射断层扫描在厄洛替尼治疗开始后两周内可以预测非小细胞肺癌患者的反应。
PLoS One. 2014 Feb 5;9(2):e87629. doi: 10.1371/journal.pone.0087629. eCollection 2014.
5
Calibration test of PET scanners in a multi-centre clinical trial on breast cancer therapy monitoring using 18F-FLT.使用 18F-FLT 对乳腺癌治疗监测进行多中心临床试验中的 PET 扫描仪校准测试。
PLoS One. 2013;8(3):e58152. doi: 10.1371/journal.pone.0058152. Epub 2013 Mar 13.
6
Liver SULmean at FDG PET/CT: interreader agreement and impact of placement of volume of interest.肝脏 SULmean 在 FDG PET/CT 中的应用:阅读者间的一致性和感兴趣区容积放置的影响。
Radiology. 2013 May;267(2):596-601. doi: 10.1148/radiol.12121385. Epub 2013 Jan 7.
7
The impact of acquisition time on image quality in whole-body 18F-FDG PET/CT for cancer staging.采集时间对用于癌症分期的全身18F-FDG PET/CT图像质量的影响。
J Nucl Med Technol. 2012 Dec;40(4):255-8. doi: 10.2967/jnmt.112.103291. Epub 2012 Oct 15.
8
Impact of point spread function reconstruction on thoracic lymph node staging with 18F-FDG PET/CT in non-small cell lung cancer.18F-FDG PET/CT 中基于点扩散函数重建对非小细胞肺癌胸内淋巴结分期的影响。
Clin Nucl Med. 2012 Oct;37(10):971-6. doi: 10.1097/RLU.0b013e318251e3d1.
9
Noise considerations for PET quantification using maximum and peak standardized uptake value.使用最大标准化摄取值和峰值标准化摄取值进行 PET 定量的噪声考虑因素。
J Nucl Med. 2012 Jul;53(7):1041-7. doi: 10.2967/jnumed.111.101733. Epub 2012 May 24.
10
Impact of the definition of peak standardized uptake value on quantification of treatment response.峰值标准化摄取值定义对治疗反应定量的影响。
J Nucl Med. 2012 Jan;53(1):4-11. doi: 10.2967/jnumed.111.093443.

对于葡萄糖代谢活跃的肿瘤,SUV 峰值是(18)F-FDG-PET/CT 定量最可靠的参数,与采集时间无关。

For avid glucose tumors, the SUV peak is the most reliable parameter for [(18)F]FDG-PET/CT quantification, regardless of acquisition time.

机构信息

Nuclear Medicine Department, University Hospital - Angers, 4 rue Larrey 49933, Angers, Cedex 09, France.

LUNAM Université - INSERM UMR-S 1066, Micro et nanomédecine biomimétiques, 4 rue Larrey 49933, Angers, Cedex 09, France.

出版信息

EJNMMI Res. 2016 Dec;6(1):21. doi: 10.1186/s13550-016-0177-8. Epub 2016 Mar 5.

DOI:10.1186/s13550-016-0177-8
PMID:26944734
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4779086/
Abstract

BACKGROUND

This study is an assessment of the impact of acquisition times on SUV with [(18)F]FDG-PET/CT on healthy livers (reference organ with stable uptake over time) and on tumors.

METHODS

One hundred six [(18)F]FDG-PET/CT were acquired in list mode over a single-bed position (livers (n = 48) or on tumors (n = 58)). Six independent datasets of different durations were reconstructed (from 1.5 to 10 min). SUVmax (hottest voxel), SUVpeak (maximum average SUV within a 1-cm(3) spherical volume), and SUVaverage were measured within a 3-cm-diameter volume of interest (VOI) in the right lobe of the liver. For [(18)F]FDG avid tumors (SUVmax ≥ 5), the SUVmax, SUVpeak, and SUV41% (isocontour threshold method) were computed.

RESULTS

For tumors, SUVpeak values did not vary with acquisition time. SUVmax displayed significant differences between 1.5- and 5-10-min reconstruction times. SUV41% was the most time-dependent parameter. For the liver, the SUVaverage was the sole parameter that did not vary over time.

CONCLUSIONS

For [(18)F]FDG avid tumors, with short acquisition times, i.e., with new generations of PET systems, the SUVpeak may be more robust than the SUVmax. The SUVaverage over a 3-cm-diameter VOI in the right lobe of the liver appears to be a good method for a robust and reproducible assessment of the hepatic metabolism.

摘要

背景

本研究评估了 acquisition times(采集时间)对 [(18)F]FDG-PET/CT 中健康肝脏(随时间摄取稳定的参考器官)和肿瘤 SUV 的影响。

方法

采用单床位(肝脏(n=48)或肿瘤(n=58))以列表模式采集了 106 次 [(18)F]FDG-PET/CT。重建了 6 个不同持续时间的独立数据集(1.5 至 10 分钟)。在右叶肝脏 3cm 直径的感兴趣区(VOI)内测量 SUVmax(热点体素)、SUVpeak(1cm3 球形体积内的最大平均 SUV)和 SUVaverage。对于 [(18)F]FDG 摄取高的肿瘤(SUVmax≥5),计算了 SUVmax、SUVpeak 和 SUV41%(等轮廓阈值法)。

结果

对于肿瘤,SUVpeak 值不受采集时间的影响。SUVmax 在 1.5-5-10 分钟重建时间之间存在显著差异。SUV41% 是最依赖时间的参数。对于肝脏,SUVaverage 是唯一不随时间变化的参数。

结论

对于 [(18)F]FDG 摄取高的肿瘤,采用短采集时间,即新一代 PET 系统,SUVpeak 可能比 SUVmax 更稳健。右叶肝脏 3cm 直径 VOI 内的 SUVaverage 似乎是一种稳健且可重复的肝脏代谢评估方法。